GenesisCare USA - Clarkston

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• ECOG-ACRIN Cancer Research Group1 trial
• Radiation Therapy Oncology Group1 trial
• SWOG Cancer Research Network1 trial

Running trials

• Active, not recruiting

  Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

  NCT04484818· Phase 3· ECOG-ACRIN Cancer Research Group· Source

• Recruiting

  Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  NCT03678025· Phase 3· SWOG Cancer Research Network· Source

  Contact: Frank A. Vicini (principal investigator)

• Active, not recruiting

  Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

  NCT01368588· Phase 3· Radiation Therapy Oncology Group· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer1 recruiting